PAR 0.00% 26.5¢ paradigm biopharmaceuticals limited..

research reports and media, page-455

  1. 6,027 Posts.
    lightbulb Created with Sketch. 1160
    Cap raise would show in the cashflow statement, not in the profit and loss. It doesn't qualify as income in accounting standards.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.